Green Alpha Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$182K	Sell	14,167 -2,526	-15%	-$32.2K	0.18%	96
2025 Q4	$150K	Buy	+16,693	New	+$230K	0.14%	108
2025 Q3	–	Sell	-11,007	Closed	-$103K	–	106
2025 Q2	$103K	Sell	11,007 -1,461	-12%	-$12K	0.1%	101
2025 Q1	$88.6K	Buy	12,468 +669	+6%	+$6.76K	0.09%	104
2024 Q4	$138K	Buy	+11,799	New	+$184K	0.11%	139
2024 Q2	–	Sell	-7,964	Closed	-$219K	–	141
2024 Q1	$219K	Sell	7,964 -2,139	-21%	-$59.4K	0.16%	129
2023 Q4	$308K	Sell	10,103 -4,674	-32%	-$134K	0.22%	131
2023 Q3	$467K	Sell	14,777 -314	-2%	-$12.2K	0.36%	94
2023 Q2	$615K	Buy	15,091 +1,187	+9%	+$48.1K	0.4%	96
2023 Q1	$518K	Sell	13,904 -1,467	-10%	-$57.5K	0.36%	103
2022 Q4	$536K	Buy	15,371 +813	+6%	+$38.7K	0.45%	89
2022 Q3	$815K	Sell	14,558 -67,941	-82%	-$4.21M	0.69%	60
2022 Q2	$4.27M	Buy	82,499 +71,748	+667%	+$3.64M	0.98%	33
2022 Q1	$781K	Buy	10,751 +1,617	+18%	+$137K	0.53%	82
2021 Q4	$1.08M	Buy	9,134 +248	+3%	+$31.1K	0.73%	61
2021 Q3	$1.19M	Sell	8,886 -370	-4%	-$56K	0.82%	47
2021 Q2	$1.5M	Sell	9,256 -738	-7%	-$57.5K	1.02%	34
2021 Q1	$802K	Buy	9,994 +5,255	+111%	+$353K	0.79%	53
2020 Q4	$258K	Buy	+4,739	New	+$172K	0.31%	90